Main content
How effective is the vaccine against the South African variant?
Prof Andrew Pollard from the Oxford Vaccine Group assesses the risk of the variant
The director of the Oxford Vaccine Group, Professor Andrew Pollard, tells Today about the efficacy of the Oxford/AstraZeneca vaccine against the South African variant. Also, Dame Clare Gerada, former chair of the Royal College of GPs and Professor Adam Finn, professor of paediatrics at the University of Bristol and member of the Joint Committee on Vaccination and Immunisation, answer your vaccine questions.
(Image: Oxford/AstraZeneca vaccine, credit: Andrew Matthews/Getty Images)
Podcast
-
![]()
Best of Today
Listen to selected highlights from the Today programme.
